dan 2163 has been researched along with olanzapine in 147 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (0.68) | 18.2507 |
| 2000's | 57 (38.78) | 29.6817 |
| 2010's | 66 (44.90) | 24.3611 |
| 2020's | 23 (15.65) | 2.80 |
| Authors | Studies |
|---|---|
| Coolen, HK; Glennon, JC; Kruse, CG; Lange, JH; Reinders, JH; Tolboom, JT | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Bayle, FJ; Ghaoui, S; Olie, JP | 1 |
| Naber, D | 1 |
| Möller, HJ | 1 |
| McAskill, R; Taylor, DM | 1 |
| Bebbington, P; Freemantle, N; Geddes, J; Harrison, P | 1 |
| Kapur, S; Remington, G | 2 |
| Agelink, MW; Klieser, E; Linka, T; Lukas, K; Majewski, T; Ullrich, H; Wurthmann, C | 1 |
| Hilger, E; Kasper, S | 1 |
| Grohmann, R; Pedrosa Gil, F; Rüther, E; Schneider, C | 1 |
| Bayle, FJ; Chereau, I; Lancon, C; Llorca, PM | 1 |
| Fleurot, O; Giudicelli, A; Lĵo, H; Martin, S; Peuskens, J; Rein, W; Thirumalai, S | 1 |
| Danileviciūte, V | 1 |
| Castle, DJ; Lambert, TJ | 1 |
| Fric, M; Laux, G | 1 |
| Henn, FA; Thome, J; Zink, M | 1 |
| Correll, CU; Kane, JM; Leucht, S | 1 |
| Bitter, I | 1 |
| Lôo, H; Martin, S; Mortimer, A; Peuskens, J | 1 |
| Bryois, Ch; Sahli, Ch | 1 |
| Amann, B; Hegerl, U; Juckel, G; Möller, HJ; Mulert, C; Pogarell, O | 1 |
| Lawrie, S; McIntosh, A; Nadeem, Z | 1 |
| Messer, T; Schmauss, M; Strasser, O | 1 |
| Kühn, KU; Maier, W; Quednow, BB; Schlaepfer, TE; Wagner, M; Westheide, J | 1 |
| Lawrie, S; McIntosh, A | 1 |
| Berk, M; Bourin, M; Dodd, S; Ivanovski, B; Lagopoulos, J; Malhi, GS; Mitchell, PB | 1 |
| Beckmann, K; Bliesener, N; Kühn, KU; Maier, W; Quednow, BB; Wagner, M; Westheide, J | 1 |
| Brown, D; Fraser, K; Martin, M; Taylor, M; Turner, M; Watt, L | 1 |
| Engel, R; Etschel, E; Hamann, J; Kane, JM; Kissling, W; Leucht, S | 1 |
| Knecht, G; Naber, D; Veismann, S; Wolf, K | 1 |
| Cipriani, A; Geddes, JR; Rendell, JM | 1 |
| Bäuml, J; Davis, JM; Engel, RR; Leucht, S | 1 |
| Baumgartner, S; Ebenbichler, C; Edlinger, M; Fleischhacker, WW; Hofer, A; Hummer, M; Kemmler, G; Lechleitner, M; Rettenbacher, MA | 1 |
| Bouhassira, M; Lancrenon, S; Lecrubier, Y; Perrin, E; Quintin, P | 1 |
| Kovács, G; Kovács, L | 1 |
| Alonso, J; Haro, JM; Lépine, JP; Novick, D; Ratcliffe, M; Suarez, D | 1 |
| Douki, S; Vanelle, JM | 1 |
| Bodner, T; Edlinger, M; Fleischhacker, WW; Hofer, A; Huber, R; Kemmler, G; Rettenbacher, MA; Sachs, G | 1 |
| Limosin, F | 1 |
| De Hert, M; Mortimer, A; Peuskens, J | 1 |
| Eich, FX; Linden, M; Pyrkosch, L | 1 |
| Hui, HY; Law, WL; You, JH; Young, WM | 1 |
| Friederich, M; Kozian, R | 1 |
| Bret, MC; Bret, P; Fourier-Réglat, A; Pariente, A | 1 |
| Altunay, IK; Kayaoğlu, S; Mercan, S; Ogutcen, O; Taskintuna, N | 1 |
| Balasubramaniam, K; Choudhary, PC; Joyce, E; Mortimer, AM; Saleem, PT | 1 |
| Cejpková, A; Rodáková, I; Svestka, J; Synek, O; Tomanová, J | 1 |
| Lawrie, SM; Shajahan, P; Taylor, M | 1 |
| Boter, H; Davidson, M; Dollfus, S; Fleischhacker, WW; Gaebel, W; Galderisi, S; Gheorghe, MD; Grobbee, DE; Hranov, LG; Hummer, M; Kahn, RS; Keet, IP; Libiger, J; Lindefors, N; López-Ibor, JJ; Peuskens, J; Riecher-Rössler, A; Rybakowski, JK; Vergouwe, Y | 1 |
| Agai Csongor, E; Domány, G; Elekes, O; Gémesi, LI; Gyertyán, I; Kapás, M; Kedves, R; Kiss, B; Laszy, J; Pásztor, G; Sághy, K; Szombathelyi, Z; Zájer-Balázs, M | 1 |
| Bai, YM; Kuo, TB; Wang, YC; Yang, CC | 1 |
| Endo, S; Hamamura, T; Ishihara, T; Kuroda, S; Miyata, S; Taoka, H; Toma, K | 1 |
| Kumar, R; Sachdev, PS | 1 |
| Ayesa, R; Crespo-Facorro, B; Martínez-Garcia, O; Mata, I; Pérez-Iglesias, R; Ramirez-Bonilla, M; Rodríguez-Sánchez, JM; Vázquez-Barquero, JL | 1 |
| Goldberg, TE; Gomar, JJ | 1 |
| Bhoopathi, PS; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schwarz, S | 1 |
| Bhowmick, S; Ghosh, M; Hazra, A | 1 |
| Ahn, YM; Hwang, SS; Jung, DC; Kim, SH; Kim, YS | 1 |
| Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S; Silveira da Mota Neto, JI | 1 |
| Burns, T; Derks, EM; Fleischhacker, WW; Gaebel, W; Kahn, RS; Riesbeck, M; Rössler, W; von Wilmsdorff, M | 1 |
| Kastania, A; Katsafouros, K; Laskos, E; Lykouras, L; Michalopoulou, PG; Papadopoulou, A; Rizos, EN; Vasilopoulos, D | 1 |
| Duggan, L; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Barnas, C; Friedrich, F; Höfer, P; Lesch, OM; Schmook, M; Spindelegger, C; Vyssoki, B; Walter, H | 1 |
| Chen, CC; Chen, YY; Hung, GC | 1 |
| Groleger, U; Novak-Grubic, V | 1 |
| Davis, JM; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Lobos, CA; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Claes, S; De Hert, M; Martens, GJ; Moons, T; Peuskens, J; Van Loo, KM; Van Schijndel, JE; van Winkel, R | 1 |
| Chen, J; Gao, K; Kemp, DE | 1 |
| Depping, AM; Gaudchau, A; Kissling, W; Komossa, K; Leucht, S | 1 |
| Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Englisch, S; Esslinger, C; Meyer-Lindenberg, A; Rausch, F; Schirmbeck, F; Zink, M | 1 |
| Amorin-Díaz, M; Lerma-Carrillo, I; López-Muñoz, F; López-Rodríguez, E; Molina, JD; Toledo-Romero, F | 1 |
| Punukollu, B; Rutherford, H | 1 |
| Bitter, I; Czobor, P; Derks, EM; Fleischhacker, WW; Kahn, RS; Libiger, J; Volavka, J | 1 |
| Czernikiewicz, A; Kucharska-Pietura, K; Mortimer, A; Tylec, A | 1 |
| Chang, YT; Chen, CC; Chen, WJ; Kuo, CJ; Lee, WC; Liao, YT; Shau, WY; Tsai, SY; Yang, SY | 1 |
| Han, C; Jeong, HG; Joe, SH; Ko, YH; Lee, HY; Lee, MS | 1 |
| Deuschle, M; Gilles, M; Kopf, D; Lederbogen, F; Lehnert, H; Medlin, F; Paslakis, G | 1 |
| Dunn, G; French, P; Hutton, P; Morrison, AP; Taylor, PJ; Yung, AR | 1 |
| Bitter, I; Bucci, P; Fleischhacker, WW; Galderisi, S; Kahn, RS; Libiger, J; Mucci, A | 1 |
| Ascher-Svanum, H; Bertsch, J; Brugnoli, R; Haro, JM; Hong, J; Novick, D | 1 |
| Bicikova, M; Hampl, R; Hill, M; Mohr, P; Ripova, D | 1 |
| Blagojević, D; Lečić-Toševski, D; Miljević, Č; Niketić, V; Nikolić, M; Nikolić-Kokić, A; Spasić, MB | 1 |
| D'iakonov, AL; Lobanova, IV | 1 |
| Bhatia, MS; Jhanjee, A; Srivastava, S | 1 |
| Couchman, L; Fisher, DS; Flanagan, RJ; Handley, SA; Morgan, PE; Partridge, SJ | 1 |
| Behr, ER; De Ponti, F; Koci, A; Moretti, U; Poluzzi, E; Raschi, E; Spina, E; Sturkenboom, M | 1 |
| Fisher, DS; Flanagan, RJ; Handley, SA; Partridge, SJ | 1 |
| Bahk, WM; Wang, HR; Woo, YS | 1 |
| Cantisani, A; Ferrari, G; Grassi, G; Pallanti, S; Poli, L; Righi, L | 1 |
| Citrome, L; Czobor, P; Van Dorn, RA; Volavka, J | 1 |
| Calandre, EP; Rico-Villademoros, F; Slim, M | 1 |
| Eifler, S; Englisch, S; Esslinger, C; Kirsch, P; Meyer-Lindenberg, A; Mier, D; Rausch, F; Schirmbeck, F; Zink, M | 1 |
| Andersen, CU; Dabrowski, K; Hansen, KB; Høimark, L; Sædder, E | 2 |
| Gillies, D; Kalakouti, E; Kyprianou, K; McLoughlin, BC; Pushpa-Rajah, JA; Rathbone, J; Variend, H | 1 |
| Cipriani, A; Davis, JM; Furukawa, TA; Goldberg, Y; Leucht, S; Levine, SZ; Samara, M; Tanaka, S | 1 |
| Adali, I; Asri, F; Benali, A; Manoudi, F; Nabih, FO | 1 |
| Arango, C; Fleischhacker, WW; Glenthøj, B; Heres, S; Kahn, RS; Kapur, S; Leboyer, M; Leucht, S; Leweke, FM; Lewis, S; McGuire, P; Meyer-Lindenberg, A; Rujescu, D; Sommer, IE; Winter-van Rossum, I | 1 |
| Joyce, DW; Mateos Fernandez, MJ; Sarkar, SN; Shergill, SS; Tracy, DK | 1 |
| Dulawa, SC; Ho, EV; Klenotich, SJ; McMurray, MS; Server, CH | 1 |
| Chang, CM; Chen, PJ; Lee, CP | 1 |
| Hsieh, CY; Kao Yang, YH; Lai, EC; Lin, SJ; Setoguchi, S; Wong, MB; Yang, YK | 1 |
| Antczak, A; Górski, P; Karbownik, MS; Kowalczyk, E; Pietras, T; Szemraj, J; Wieteska, Ł | 1 |
| Furtado, VA; Li, BG; Sampford, JR; Sampson, S; Xia, J; Zhao, S | 1 |
| Bas, A; Bas, TO; Duran, A; Emul, M; Gultekin, G; Incir, S | 1 |
| Bonarek, P; Chmielińska, A; Dziedzicka-Wasylewska, M; Polit, A; Skrobecki, P; Stepien, P; Wisniewska-Becker, A | 1 |
| Becker, R; Gass, N; Künnecke, B; Lebhardt, P; Meyer-Lindenberg, A; Reinwald, J; Risterucci, C; Sack, M; Sartorius, A; Schwarz, AJ; Tollens, F; Weber-Fahr, W | 1 |
| Zipursky, RB | 1 |
| Arango, C; Dazzan, P; Díaz-Caneja, CM; Drake, R; Eijkemans, MJC; Fleischhacker, WW; Galderisi, S; Glenthøj, B; Heres, S; Kahn, RS; Kapur, S; Leboyer, M; Leucht, S; Lewis, SW; McGuire, P; Rujescu, D; Sommer, IE; Weiser, M; Winter van Rossum, I | 1 |
| Jasińska-Stroschein, M; Jóźwiak-Bębenista, M; Kowalczyk, E | 1 |
| Li, C; Men, P; Qu, S; Xiong, T; Yi, Z; Yu, X; Zhai, S | 1 |
| Kahn, RS; Sommer, IE | 1 |
| Allan, S; Bradstreet, S; Gumley, A; Heriot-Maitland, C | 1 |
| Davis, JM; Leucht, S; Smith, RC | 1 |
| Aguirre, C; Erezuma, I; Garcia, M; Hernandez, R; Lertxundi, U; Medrano, J | 1 |
| Li, P; Liu, X; Wang, J; Wang, Y; Yang, L; Zheng, L; Zhou, H; Zhou, Z | 1 |
| Kiss, A; Koprdova, R; Osacka, J; Pecenak, J | 1 |
| Baumgärtner, J; Brockhaus-Dumke, A; Cordes, J; Correll, CU; Engelke, C; Englisch, S; Feyerabend, S; Gaebel, W; Gouzoulis-Mayfrank, E; Gründer, G; Hasan, A; Heres, S; Jäger, M; Kluge, M; Kolbe, H; Lange, C; Langguth, B; Leucht, S; Makiol, C; Meisenzahl-Lechner, E; Neff, A; Poeppl, T; Reske, D; Riesbeck, M; Schmidt-Kraepelin, C; Verde, PE; Wobrock, T; Zink, M | 1 |
| Kiss, A; Osacka, J | 4 |
| Kraats, GV; Luykx, JJ; van Ojen, R | 1 |
| Bar Haim, M; Burshtein, S; Davidson, M; Heres, S; Kahn, RS; Levi, L; Shenkman, G; Weiser, M; Winter-Van Rossum, I | 1 |
| Li, C; Men, P; Qu, S; Yi, ZM; Yu, X; Zhai, S | 1 |
| Le, J; Li, Y; Wang, S; Yuan, T | 1 |
| Claro, A; Corte-Real, F; Franco, J; Monteiro, C; Mustra, C; Proença, P | 1 |
| Davis, JM; Leucht, S | 1 |
| Alisauskiene, R; Anda, LG; Bartz-Johannessen, C; Berle, JØ; Bjarke, J; Fathian, F; Fleischhacker, WW; Hugdahl, K; Joa, I; Johnsen, E; Kjelby, E; Kroken, RA; Larsen, TK; Løberg, EM; Reitan, SK; Rettenbacher, M; Sinkeviciute, I; Skrede, S; Stabell, L; Steen, VM; Walla, B | 1 |
| Baandrup, L; Ebdrup, BH | 1 |
| Johnsen, E; Kroken, RA; Steen, VM | 1 |
| Hadryś, T; Rymaszewska, J | 1 |
| Baumgärtner, J; Brockhaus-Dumke, A; Cordes, J; Correll, CU; Engelke, C; Englisch, S; Feyerabend, S; Gouzoulis-Mayfrank, E; Gründer, G; Hasan, A; Jäger, M; Kluge, M; Lange, C; Langguth, B; Leucht, S; Makiol, C; Meisenzahl-Lechner, E; Neff, A; Poeppl, TB; Reske, D; Riesbeck, M; Schmidt-Kraepelin, C; Verde, PE; Zink, M | 1 |
| Correll, CU; Hagi, K; Kane, JM; Kishimoto, T; Kurokawa, S | 1 |
| Byeon, SJ; Chung, SJ; Oh, S | 1 |
| Johannesen, CAB; Johnsen, E; Kroken, RA; Larsen, TK; Løberg, EM; Mørkved, N; Rettenbacher, MA; Thimm, JC; Winje, D | 1 |
| Osman, E; Yıldız, M | 1 |
| Bauer, M; Cordes, J; Davis, JM; Dehelean, L; Feyerabend, S; Fran, E; Hahn, E; Heres, S; Horowitz, M; Juckel, G; Ladea, M; Landgrebe, M; Lang, FU; Langguth, B; Lautenschlager, M; Leucht, S; Leweke, FM; Matei, V; Musil, R; Naber, D; Papava, I; Petcu C, C; Riedel, M; Ruhrmann, S; Schmidt-Kraepelin, C; Spellmann, I; Stefanescu, C; Ta, TMT; Tamasan, SC; van der List, T; Wolff-Menzler, C; Zamora, D | 1 |
| Heres, S; Leucht, S; Schreyer, KF; Steimer, W | 1 |
| Cai, J; Gao, M; Huang, J; Huang, Y; Kang, D; Li, L; Liu, F; Long, Y; Ou, J; Peng, X; Shao, P; Shao, T; Shen, Y; Song, C; Su, Y; Sun, M; Wang, W; Wang, X; Wu, Q; Wu, R; Xiao, J; Xie, P; Yang, Y | 1 |
| Blindheim, A; Gjestad, R; Joa, I; Johnsen, E; Kroken, RA; Løberg, EM; Munk-Jørgensen, P; Reitan, SK; Rettenbacher, M; Stabell, LA | 1 |
| Cai, J; Chen, Y; Fang, M; Hu, J; Huang, M; Liu, F; Liu, T; Liu, Z; Long, Y; Meng, H; Song, X; Tang, Y; Wan, C; Wang, X; Wang, Z; Wu, Q; Wu, R; Wu, X; Xiao, J; Xu, X; Xu, Y; Yang, Y; Zhang, R; Zhao, J; Zheng, Y | 1 |
38 review(s) available for dan 2163 and olanzapine
| Article | Year |
|---|---|
[New antipsychotic agents].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles | 1999 |
[New i.e. atypical neuroleptic agents for negative symptoms of schizophrenia: results and methodological problems of evaluation].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Imidazoles; Indoles; Neurotransmitter Agents; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles | 2000 |
Atypical antipsychotics and weight gain--a systematic review.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles; Weight Gain | 2000 |
Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Costs; Humans; Imidazoles; Indoles; Olanzapine; Pirenzepine; Quetiapine Fumarate; Regression Analysis; Risperidone; Schizophrenia; Sulpiride | 2000 |
Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Dopamine Antagonists; Drug Monitoring; Haloperidol; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Receptors, Dopamine D2; Receptors, Dopamine D4; Risperidone; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Sulpiride; Thiazoles; Treatment Outcome | 2001 |
[Atypical neuroleptics: new approaches to drug therapy of schizophrenic disorders].
Topics: Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Dibenzothiepins; Haloperidol; Humans; Imidazoles; Indoles; Multicenter Studies as Topic; Olanzapine; Piperazines; Pirenzepine; Placebos; Quetiapine Fumarate; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulpiride; Thiazoles | 2000 |
Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Models, Neurological; Olanzapine; Pirenzepine; Quetiapine Fumarate; Receptors, Dopamine D2; Risperidone; Schizophrenia; Sulpiride | 2001 |
Tardive dyskinesias and antipsychotics: a review.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dyskinesia, Drug-Induced; Humans; Olanzapine; Pirenzepine; Prevalence; Psychotic Disorders; Risperidone; Sulpiride | 2002 |
[Schizoaffective disorder: clinical symptoms and present-day approach to treatment].
Topics: Adolescent; Amisulpride; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Child; Diagnosis, Differential; Dibenzothiazepines; Dogs; Female; Humans; Imidazoles; Indoles; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Piperazines; Pirenzepine; Placebos; Prognosis; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Thiazoles; Time Factors | 2002 |
Pharmacological approaches to the management of schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia; Sulpiride | 2003 |
Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Child; Dibenzothiazepines; Double-Blind Method; Dyskinesia, Drug-Induced; Haloperidol; Humans; Middle Aged; Neurologic Examination; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risk; Sulpiride; Thiazoles | 2004 |
[Current pharmacotherapy of schizophrenia].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Serotonin Antagonists; Sulpiride; Thiazoles | 2004 |
[Psychotropics and weight gain].
Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Child; Clozapine; Dibenzothiazepines; Double-Blind Method; Female; Fructose; Haloperidol; Humans; Imidazoles; Indoles; Male; Obesity; Olanzapine; Piperazines; Placebos; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Socioeconomic Factors; Sulpiride; Thiazoles; Time Factors; Topiramate; Valproic Acid; Weight Gain | 2004 |
Schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Clozapine; Cognitive Behavioral Therapy; Dibenzothiepins; Haloperidol; Humans; Olanzapine; Patient Compliance; Perazine; Pimozide; Risperidone; Schizophrenia; Sulpiride | 2003 |
Schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Clozapine; Haloperidol; Humans; Olanzapine; Patient Compliance; Perazine; Pimozide; Risperidone; Schizophrenia; Sulpiride | 2004 |
A typical mood stabilizers: a "typical role for atypical antipsychotics.
Topics: Affect; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Secondary Prevention; Sulpiride; Thiazoles | 2005 |
Haloperidol alone or in combination for acute mania.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Dibenzothiazepines; Drug Therapy, Combination; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Valproic Acid | 2006 |
[The use of atypical antipsychotics in the long-term care of schizophrenia].
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Cognition Disorders; Drug Tolerance; Dyskinesia, Drug-Induced; Haloperidol; Humans; Olanzapine; Piperazines; Quinolones; Risperidone; Schizophrenia; Sulpiride; Time Factors | 2006 |
Akathisia and second-generation antipsychotic drugs.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Isoxazoles; Olanzapine; Piperazines; Piperidines; Prevalence; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risk Factors; Risperidone; Sulpiride; Thiazoles | 2009 |
Ziprasidone versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2009 |
Amisulpride versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Humans; Olanzapine; Piperazines; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2010 |
Olanzapine versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2010 |
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Cholesterol; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Weight Gain | 2010 |
Second-generation antipsychotics in major depressive disorder: update and clinical perspective.
Topics: Adult; Amisulpride; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Drug Therapy, Combination; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Sulpiride | 2011 |
Second-generation antipsychotics for major depressive disorder and dysthymia.
Topics: Amisulpride; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Dysthymic Disorder; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Sulpiride | 2010 |
Risperidone versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2011 |
Atypical antipsychotics in the treatment of delirium.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Delirium; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Thiazoles | 2013 |
Current status of atypical antipsychotics for the treatment of fibromyalgia.
Topics: Amisulpride; Antipsychotic Agents; Anxiety; Benzodiazepines; Comorbidity; Depression; Dibenzothiazepines; Fibromyalgia; Humans; Olanzapine; Patient Selection; Piperazines; Quetiapine Fumarate; Sulpiride; Thiazoles; Treatment Outcome | 2014 |
[Sparse evidence of antipsychotic drugs for the treatment of delirium].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Delirium; Evidence-Based Medicine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles | 2014 |
Cannabis and schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Cannabinoids; Humans; Marijuana Abuse; Medical Marijuana; Olanzapine; Psychotherapy; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride | 2014 |
[Sparse evidence of antipsychotic drugs for the treatment of delirium].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Delirium; Evidence-Based Medicine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles | 2014 |
Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Drug Monitoring; Female; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sulpiride; Treatment Outcome | 2015 |
The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Disease Management; Europe; Humans; Multicenter Studies as Topic; Olanzapine; Outcome Assessment, Health Care; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Sulpiride | 2015 |
Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
Topics: Administration, Oral; Amisulpride; Antipsychotic Agents; Benzodiazepines; Fluphenazine; Humans; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome | 2016 |
Comparative efficacy and safety between amisulpride and olanzapine in schizophrenia treatment and a cost analysis in China: a systematic review, meta-analysis, and cost-minimization analysis.
Topics: Amisulpride; Antipsychotic Agents; Brief Psychiatric Rating Scale; China; Cost-Benefit Analysis; Female; Humans; Male; Olanzapine; Schizophrenia; Treatment Outcome | 2018 |
Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis.
Topics: Amisulpride; Antidepressive Agents; Antipsychotic Agents; Clozapine; Depression; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2019 |
Amisulpride - is it as all other medicines or is it different? An update.
Topics: Administration, Oral; Amisulpride; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Humans; Neurosecretory Systems; Olanzapine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology | 2020 |
Efficacy and safety/tolerability of antipsychotics in the treatment of adult patients with major depressive disorder: a systematic review and meta-analysis.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Humans; Olanzapine; Quetiapine Fumarate; Risperidone | 2023 |
29 trial(s) available for dan 2163 and olanzapine
| Article | Year |
|---|---|
Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine.
Topics: Adult; Amisulpride; Antipsychotic Agents; Autonomic Nervous System; Benzodiazepines; Clozapine; Electrocardiography; Female; Heart; Heart Rate; Humans; Imidazoles; Indoles; Male; Middle Aged; Olanzapine; Pirenzepine; Prospective Studies; Sulpiride | 2001 |
A double-blind, randomised comparative trial of amisulpride versus olanzapine in the treatment of schizophrenia: short-term results at two months.
Topics: Adolescent; Adult; Aged; Amisulpride; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Body Weight; Double-Blind Method; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Sulpiride; Time Factors | 2002 |
A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Double-Blind Method; Female; Humans; Male; Middle Aged; Olanzapine; Quality of Life; Schizophrenia; Sulpiride; Treatment Outcome | 2004 |
Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism: randomized controlled trial of olanzapine vs amisulpride.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Attention; Benzodiazepines; Cognition; Dose-Response Relationship, Drug; Female; Humans; Male; Memory; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Olanzapine; Psychiatric Status Rating Scales; Psychomotor Performance; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Serotonin; Sulpiride; Verbal Learning | 2005 |
Sensorimotor gating and habituation of the startle response in schizophrenic patients randomly treated with amisulpride or olanzapine.
Topics: Acoustic Stimulation; Adult; Amisulpride; Antipsychotic Agents; Attention; Benzodiazepines; Dopamine D2 Receptor Antagonists; Follow-Up Studies; Habituation, Psychophysiologic; Humans; Longitudinal Studies; Middle Aged; Olanzapine; Receptors, Dopamine D3; Reference Values; Reflex, Startle; Schizophrenia; Schizophrenic Psychology; Serotonin 5-HT2 Receptor Antagonists; Sulpiride | 2006 |
Early changes of plasma lipids during treatment with atypical antipsychotics.
Topics: Adolescent; Adult; Aged; Amisulpride; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Cholesterol; Clozapine; Humans; Lipids; Middle Aged; Olanzapine; Piperazines; Prospective Studies; Schizophrenia; Sulpiride; Thiazoles; Time Factors; Triglycerides | 2006 |
The treatment of negative symptoms and deficit states of chronic schizophrenia: olanzapine compared to amisulpride and placebo in a 6-month double-blind controlled clinical trial.
Topics: Adult; Affect; Amisulpride; Antipsychotic Agents; Attention; Basal Ganglia Diseases; Benzodiazepines; Brief Psychiatric Rating Scale; Chronic Disease; Depression; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Olanzapine; Psychotic Disorders; Recurrence; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sulpiride; Surveys and Questionnaires | 2006 |
A double-blind randomised comparative trial of amisulpride versus olanzapine for 2 months in the treatment of subjects with schizophrenia and comorbid depression.
Topics: Adult; Amisulpride; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Comorbidity; Depressive Disorder; Double-Blind Method; Female; France; Humans; Italy; Male; Olanzapine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Sulpiride; Time Factors; Treatment Outcome; Triglycerides; Tunisia; Weight Gain | 2006 |
Metabolic control in patients with schizophrenia treated with amisulpride or olanzapine.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Mass Index; Body Weight; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Risk Factors; Schizophrenia; Sulpiride | 2007 |
Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia.
Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Prognosis; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2007 |
Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Dibenzothiepins; Female; Humans; Hyperprolactinemia; Middle Aged; Olanzapine; Prolactin; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; Statistics, Nonparametric; Sulpiride | 2007 |
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Haloperidol; Humans; Linear Models; Male; Olanzapine; Patient Compliance; Piperazines; Proportional Hazards Models; Quetiapine Fumarate; Schizophrenia; Sulpiride; Thiazoles; Treatment Outcome | 2008 |
Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Cognition Disorders; Female; Follow-Up Studies; Haloperidol; Humans; Male; Neuropsychological Tests; Olanzapine; Perphenazine; Piperazines; Prospective Studies; Psychotic Disorders; Risperidone; Severity of Illness Index; Sulpiride; Thiazoles | 2009 |
Amisulpride versus olanzapine in the treatment of schizophrenia in Indian patients: randomized controlled trial.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Drug Administration Schedule; Female; Follow-Up Studies; Humans; India; Male; Olanzapine; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Sleep Initiation and Maintenance Disorders; Sulpiride; Treatment Outcome; Tremor; Weight Gain | 2010 |
Drug attitude as predictor for effectiveness in first-episode schizophrenia: Results of an open randomized trial (EUFEST).
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Medication Adherence; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; ROC Curve; Schizophrenia; Schizophrenic Psychology; Sulpiride; Surveys and Questionnaires; Thiazoles; Treatment Outcome | 2010 |
Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST).
Topics: Adult; Aggression; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Haloperidol; Hostility; Humans; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles; Treatment Outcome | 2011 |
Insulin secretion and sensitivity after single-dose amisulpride, olanzapine or placebo in young male subjects: double blind, cross-over glucose clamp study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; C-Peptide; Cross-Over Studies; Double-Blind Method; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Insulin Secretion; Male; Olanzapine; Proinsulin; Sulpiride | 2012 |
Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Neuropsychological Tests; Olanzapine; Piperazines; Psychomotor Disorders; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles; Treatment Outcome; Young Adult | 2013 |
Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.
Topics: Adult; Aggression; Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Haloperidol; Hostility; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles | 2014 |
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Clozapine; Europe; Female; Humans; Male; Olanzapine; Schizophrenia; Treatment Outcome; Young Adult | 2018 |
A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design.
Topics: Acute Disease; Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combination; Humans; Middle Aged; Multicenter Studies as Topic; Olanzapine; Randomized Controlled Trials as Topic; Research Design; Schizophrenia; Young Adult | 2020 |
Duration of untreated psychosis and response to treatment: an analysis of response in the OPTiMiSE cohort.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Cohort Studies; Double-Blind Method; Europe; Female; Humans; Male; Olanzapine; Psychotic Disorders; Time Factors; Treatment Outcome; Young Adult | 2020 |
Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Aripiprazole; Female; Humans; Male; Middle Aged; Norway; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Treatment Outcome; Weight Gain; Young Adult | 2020 |
Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial.
Topics: Adolescent; Adult; Aged; Amisulpride; Bayes Theorem; Double-Blind Method; Female; Humans; Male; Middle Aged; Olanzapine; Schizophrenia; Treatment Outcome; Young Adult | 2022 |
Impact of childhood trauma on antipsychotic effectiveness in schizophrenia spectrum disorders: A prospective, pragmatic, semi-randomized trial.
Topics: Adverse Childhood Experiences; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Olanzapine; Prospective Studies; Risperidone; Schizophrenia | 2022 |
Changing the Antipsychotic in Early Nonimprovers to Amisulpride or Olanzapine: Randomized, Double-Blind Trial in Patients With Schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Humans; Olanzapine; Schizophrenia; Treatment Outcome | 2022 |
Genetic association of the rs17782313 polymorphism with antipsychotic-induced weight gain.
Topics: Amisulpride; Antipsychotic Agents; Genome-Wide Association Study; Humans; Olanzapine; Polymorphism, Single Nucleotide; Weight Gain | 2023 |
Clinical insight among persons with schizophrenia spectrum disorders treated with amisulpride, aripiprazole or olanzapine: a semi-randomised trial.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Humans; Olanzapine; Schizophrenia | 2023 |
Early non-response as a predictor of later non-response to antipsychotics in schizophrenia: a randomized trial.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Humans; Olanzapine; Risperidone; Schizophrenia; Treatment Outcome | 2023 |
80 other study(ies) available for dan 2163 and olanzapine
| Article | Year |
|---|---|
Principal component analysis differentiates the receptor binding profiles of three antipsychotic drug candidates from current antipsychotic drugs.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzoxazines; Biogenic Monoamines; Humans; Hyperprolactinemia; Indoles; Metabolic Diseases; Phthalimides; Piperazines; Principal Component Analysis; Pyridines; Radioligand Assay; Receptors, Biogenic Amine; Weight Gain | 2007 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Atypical antipsychotics].
Topics: Acute Disease; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cost-Benefit Analysis; Dibenzothiazepines; Dibenzothiepins; Dyskinesia, Drug-Induced; Germany; Humans; Neurotransmitter Agents; Olanzapine; Patient Compliance; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride | 2000 |
[Incompatibility of olanzapine and amisulpride in multisystemic myotonic myopathy].
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Creatine Kinase; Drug Interactions; Genetic Predisposition to Disease; Humans; Male; Malignant Hyperthermia; Muscle, Skeletal; Myotonic Disorders; Olanzapine; Pirenzepine; Remission Induction; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome | 2001 |
[Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics].
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Olanzapine; Pirenzepine; Product Surveillance, Postmarketing; Prolactin; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Sulpiride | 2003 |
Combination of amisulpride and olanzapine in treatment-resistant schizophrenic psychoses.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Psychotic Disorders; Retrospective Studies; Schizophrenia; Sulpiride | 2004 |
EEG abnormalities under treatment with atypical antipsychotics: effects of olanzapine and amisulpride as compared to haloperidol.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Chi-Square Distribution; Dose-Response Relationship, Drug; Electroencephalography; Female; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Schizophrenia; Sulpiride | 2004 |
[Rehospitalization rates of newly diagnosed schizophrenic patients on atypical neuroleptic medication].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Follow-Up Studies; Germany; Humans; Long-Term Care; Male; Middle Aged; Olanzapine; Patient Readmission; Retrospective Studies; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome; Treatment Refusal | 2004 |
Atypical anti-psychotics in the real world--a naturalistic comparative outcome study.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Patient Compliance; Probability; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Quality of Life; Quetiapine Fumarate; Risk Assessment; Risperidone; Severity of Illness Index; Statistics, Nonparametric; Sulpiride; Treatment Outcome | 2005 |
Clinical implications of Brief Psychiatric Rating Scale scores.
Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Schizophrenia; Severity of Illness Index; Sulpiride; Treatment Outcome | 2005 |
[Treatment resistant schizophrenia, residual subtype: symptom improvement after additional treatment with amisulpride].
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Commitment of Mentally Ill; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Haloperidol; Homicide; Humans; Insanity Defense; Male; Olanzapine; Prisoners; Schizophrenia, Paranoid; Sulpiride; Treatment Outcome | 2006 |
Is the superior efficacy of new generation antipsychotics an artifact of LOCF?
Topics: Amisulpride; Artifacts; Benzodiazepines; Bias; Flupenthixol; Haloperidol; Humans; Olanzapine; Patient Dropouts; Psychiatric Status Rating Scales; Psychotropic Drugs; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2007 |
[Endocrine side effects among psychiatric patients treated with antipsychotics].
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Breast; Dibenzothiazepines; Endocrine System; Female; Galactorrhea; Gynecomastia; Humans; Male; Olanzapine; Piperazines; Prolactin; Quetiapine Fumarate; Quinolones; Schizophrenia; Sulpiride | 2006 |
Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study.
Topics: Adult; Ambulatory Care; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cohort Studies; Dibenzothiazepines; Europe; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Olanzapine; Prospective Studies; Quetiapine Fumarate; Recurrence; Risk Factors; Risperidone; Schizophrenia; Sulpiride; Time Factors; Treatment Outcome | 2006 |
Outcomes in schizophrenia outpatients treated with amisulpride or olanzapine.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Outpatients; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Schizophrenic Psychology; Social Behavior; Sulpiride; Treatment Outcome; Weight Gain | 2007 |
Do differences in atypical antipsychotics matter in routine practice? Medication switch from olanzapine and risperidone to amisulpride.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Drug Utilization; Dyskinesia, Drug-Induced; Female; Germany; Humans; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Schizophrenic Psychology; Structure-Activity Relationship; Sulpiride; Weight Gain | 2007 |
Atypical antipsychotic therapy for treatment of schizophrenia in Hong Kong Chinese patients--a cost analysis.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; China; Cost of Illness; Cost-Benefit Analysis; Databases, Factual; Delayed-Action Preparations; Dibenzothiazepines; Female; Health Care Costs; Hong Kong; Hospitalization; Humans; Male; Medical Records; Middle Aged; Olanzapine; Quetiapine Fumarate; Regression Analysis; Retrospective Studies; Risperidone; Schizophrenia; Substance-Related Disorders; Sulpiride | 2007 |
[Gilles-de-la-Tourette Syndrome as a Tardive Dyskinesia].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Long-Term Care; Male; Middle Aged; Olanzapine; Promethazine; Sulpiride; Tourette Syndrome; Verbal Behavior | 2007 |
The use of atypical antipsychotics in French psychiatric hospitals.
Topics: Adult; Age Factors; Amisulpride; Antimanic Agents; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; France; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Middle Aged; Olanzapine; Practice Patterns, Physicians'; Psychotic Disorders; Risperidone; Sex Factors; Sulpiride | 2007 |
Atypical antipsychotic drugs in the treatment of delusional parasitosis.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Myocardial Infarction; Olanzapine; Parasitic Diseases; Paresthesia; Patient Compliance; Risperidone; Schizophrenia, Paranoid; Somatoform Disorders; Sulpiride; Treatment Outcome | 2007 |
Comparing the use and discontinuation of antipsychotics in clinical practice: an observational study.
Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Drug Administration Schedule; Female; Humans; Male; Medical Records; Middle Aged; Olanzapine; Patient Admission; Polypharmacy; Practice Patterns, Physicians'; Quetiapine Fumarate; Research Design; Retrospective Studies; Risperidone; Schizophrenia; Scotland; Sulpiride | 2008 |
Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: II. behavioural characterisation of RG-15.
Topics: Amisulpride; Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Biological Availability; Catalepsy; Clozapine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Motor Activity; Olanzapine; Pyridines; Rats; Rats, Wistar; Receptors, Dopamine D3; Sulfonamides; Sulpiride; Tissue Distribution | 2008 |
Heart rate variability in schizophrenic patients switched from typical antipsychotic agents to amisulpride and olanzapine. 3-month follow-up.
Topics: Amisulpride; Antipsychotic Agents; Autonomic Nervous System; Benzodiazepines; Female; Heart Rate; Humans; Male; Middle Aged; Olanzapine; Schizophrenia; Statistics, Nonparametric; Sulpiride | 2008 |
Antipsychotics possessing antidepressive efficacy increase Golf protein in rat striatum.
Topics: Amisulpride; Animals; Antipsychotic Agents; Benzodiazepines; Blotting, Western; Clozapine; Corpus Striatum; Depressive Disorder; Dose-Response Relationship, Drug; GTP-Binding Protein alpha Subunits; Haloperidol; Injections, Intraperitoneal; Male; Olanzapine; Rats; Rats, Wistar; Risperidone; Sulpiride; Time Factors | 2008 |
Targeting cognition in schizophrenia research: from etiology to treatment.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Cognition; Cognition Disorders; Dibenzothiazepines; Drug Administration Schedule; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Reaction Time; Schizophrenia; Sulpiride; Thiazoles | 2009 |
The effects of psychopathology on subjective experience of side effects of antipsychotics in patients with schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Anxiety; Benzodiazepines; Cognition Disorders; Depressive Disorder; Female; Humans; Linear Models; Male; Models, Psychological; Olanzapine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2010 |
Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Brain-Derived Neurotrophic Factor; Case-Control Studies; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Sulpiride; Treatment Failure | 2010 |
Hyperprolactinaemia and acute psychosis: prolactinoma or medication-induced phenomenon?
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Middle Aged; Olanzapine; Pituitary Gland; Pituitary Neoplasms; Prolactinoma; Psychotic Disorders; Remission, Spontaneous; Sulpiride; Thyrotropin-Releasing Hormone | 2010 |
Tardive dystonia induced by switch of atypical antipsychotics.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Olanzapine; Schizophrenia; Sulpiride | 2010 |
Gender, psychosis and psychotropic drugs: differences and similarities.
Topics: Acute Disease; Adult; Affect; Amisulpride; Antipsychotic Agents; Benzodiazepines; Brain; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hospitalization; Humans; Internal-External Control; Male; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Sex Factors; Sulpiride; Thinking | 2010 |
Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugs.
Topics: Adult; Age Factors; Alleles; Amisulpride; Anthropometry; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Composition; Body Mass Index; CLOCK Proteins; Clozapine; Dibenzothiazepines; Drug Therapy, Combination; Female; Genetic Association Studies; Genetic Carrier Screening; Genotype; Humans; Long-Term Care; Male; Middle Aged; Mutation, Missense; Olanzapine; Period Circadian Proteins; Piperazines; Polymorphism, Single Nucleotide; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Receptor, Melanocortin, Type 3; Receptors, Glucocorticoid; Receptors, Leptin; Risperidone; Schizophrenia; Sex Factors; Sulpiride; Syndecan-3 | 2011 |
Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Comorbidity; Female; Germany; Humans; Male; Matched-Pair Analysis; Obsessive-Compulsive Disorder; Olanzapine; Piperazines; Prevalence; Quinolones; Schizophrenia; Serotonin Antagonists; Severity of Illness Index; Sulpiride | 2011 |
Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Antagonists; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Retrospective Studies; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sulpiride; Young Adult | 2011 |
Serum creatine kinase elevation associated with olanzapine treatment.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Creatine Kinase; Humans; Male; Olanzapine; Sulpiride | 2008 |
Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs.
Topics: Adult; Amisulpride; Analysis of Variance; Antipsychotic Agents; Attention; Benzodiazepines; Dibenzothiazepines; Emotions; Fluphenazine; Haloperidol; Humans; Memory; Middle Aged; Olanzapine; Perazine; Perphenazine; Quetiapine Fumarate; Recognition, Psychology; Risperidone; Schizophrenia; Sulpiride | 2012 |
Second-generation antipsychotic medications and risk of pneumonia in schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Clozapine; Cohort Studies; Dibenzothiazepines; Dibenzothiepins; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Olanzapine; Pneumonia; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Sulpiride; Taiwan | 2013 |
Changes in sexual function and gonadal axis hormones after switching to aripiprazole in male schizophrenia patients: a prospective pilot study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Estradiol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Olanzapine; Pilot Projects; Piperazines; Prolactin; Prospective Studies; Quinolones; Retreatment; Risperidone; Schizophrenia; Sex Hormone-Binding Globulin; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Sulpiride; Testosterone | 2012 |
Effects of drop-out on efficacy estimates in five Cochrane reviews of popular antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Data Interpretation, Statistical; Dibenzothiazepines; Humans; Olanzapine; Patient Dropouts; Piperazines; Quetiapine Fumarate; Quinolones; Review Literature as Topic; Risperidone; Schizophrenia; Sulpiride | 2012 |
Antipsychotic monotherapy and polypharmacy in the treatment of outpatients with schizophrenia in the European Schizophrenia Outpatient Health Outcomes Study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Europe; Female; Humans; Logistic Models; Male; Olanzapine; Polypharmacy; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; Sulpiride; Time Factors | 2012 |
Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Female; Humans; Male; Metabolome; Metabolomics; Middle Aged; Models, Biological; Olanzapine; Schizophrenia; Steroids; Sulpiride; Young Adult | 2013 |
Effect of atypical antipsychotics on antioxidant enzyme activities in human erythrocytes (in vitro study).
Topics: Adult; Amisulpride; Antioxidants; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Catalase; Clozapine; Dibenzothiazepines; Enzyme Activation; Erythrocytes; Glutathione Peroxidase; Glutathione Reductase; Humans; Imidazoles; Indoles; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Sulpiride; Superoxide Dismutase; Superoxide Dismutase-1; Thiazoles; Treatment Outcome; Young Adult | 2013 |
[The comparative study on the efficacy of the combination of serotonin reuptake inhibitor antidepressants and antipsychotics in the treatment of recurrent depressive disorders].
Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Olanzapine; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulpiride; Treatment Outcome; Young Adult | 2012 |
Delusional infestation: a clinical profile.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Delusions; Ectoparasitic Infestations; Female; Humans; Male; Middle Aged; Olanzapine; Risperidone; Sulpiride; Treatment Outcome | 2013 |
LC-MS/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Female; Forensic Toxicology; Hemolysis; Humans; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Quinolones; Reproducibility of Results; Risperidone; Saliva; Serum; Sulpiride; Tandem Mass Spectrometry | 2013 |
Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database.
Topics: Adverse Drug Reaction Reporting Systems; Amisulpride; Antipsychotic Agents; Arrhythmias, Cardiac; Benzodiazepines; Cardiotoxins; Cardiovascular Agents; Databases, Pharmaceutical; Death, Sudden, Cardiac; Female; Humans; Male; Olanzapine; Phenothiazines; Risk; Sulpiride; Tachycardia; Torsades de Pointes; United States; United States Food and Drug Administration; Ventricular Fibrillation | 2013 |
Stability of some atypical antipsychotics in human plasma, haemolysed whole blood, oral fluid, human serum and calf serum.
Topics: Amisulpride; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cattle; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Drug Stability; Female; Forensic Toxicology; Hemolysis; Humans; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Quinolones; Reproducibility of Results; Risperidone; Saliva; Serum; Sulpiride; Tandem Mass Spectrometry | 2013 |
Hypochondriasis and obsessive-compulsive disorder in schizophrenic patients treated with clozapine vs other atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Comorbidity; Female; Humans; Hypochondriasis; Male; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Paliperidone Palmitate; Prevalence; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2014 |
Increased orbitofrontal cortex activation associated with "pro-obsessive" antipsychotic treatment in patients with schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain Mapping; Clozapine; Executive Function; Female; Humans; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Obsessive Behavior; Olanzapine; Piperazines; Prefrontal Cortex; Psychiatric Status Rating Scales; Psychomotor Performance; Quinolones; Schizophrenia; Sulpiride | 2015 |
[Association of atypical neuroleptics with anticonvulsants and malignant syndrome. Report of 2 cases].
Topics: Adolescent; Adult; Amisulpride; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Drug Therapy, Combination; Female; Humans; Male; Neuroleptic Malignant Syndrome; Olanzapine; Sulpiride; Valproic Acid | 2014 |
Skating on thin ice: pragmatic prescribing for medication refractory schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Drug Prescriptions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Schizophrenia; Schizophrenic Psychology; Sulpiride; Valproic Acid | 2015 |
Dopamine D2/3 receptor antagonism reduces activity-based anorexia.
Topics: Amisulpride; Animals; Anorexia Nervosa; Benzodiazepines; Disease Models, Animal; Dopamine D2 Receptor Antagonists; Eating; Female; Indoles; Mice; Mice, Inbred BALB C; Motor Activity; Nitriles; Olanzapine; Piperidines; Receptors, Dopamine D3; Salicylamides; Sulpiride; Tetrahydroisoquinolines; Weight Loss | 2015 |
Heat stroke during treatment with olanzapine, trihexyphenidyl, and trazodone in a patient with schizophrenia.
Topics: Amisulpride; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Body Temperature Regulation; Critical Care; Diagnosis, Differential; Drug Interactions; Heat Stroke; Humans; Male; Middle Aged; Olanzapine; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; Sulpiride; Trazodone; Trihexyphenidyl | 2015 |
Comparative risk of oral ulcerations among antipsychotics users - population-based retrospective cohort study.
Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Databases, Factual; Female; Humans; Male; Middle Aged; Olanzapine; Oral Ulcer; Population Surveillance; Quetiapine Fumarate; Retrospective Studies; Sulpiride; Taiwan; Young Adult | 2016 |
Antipsychotic Drugs Differentially Affect mRNA Expression of Genes Encoding the Neuregulin 1-Downstream ErbB4-PI3K Pathway.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Cell Line, Tumor; Cell Survival; Clozapine; Gene Expression Regulation; Haloperidol; Humans; Neuregulin-1; Olanzapine; Phosphatidylinositol 3-Kinases; Quetiapine Fumarate; Receptor, ErbB-4; RNA, Messenger; Schizophrenia; Sulpiride | 2016 |
Level of serum thioredoxin and correlation with neurocognitive functions in patients with schizophrenia using clozapine and other atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Sulpiride; Thioredoxins; Young Adult | 2017 |
Sulpiride, Amisulpride, Thioridazine, and Olanzapine: Interaction with Model Membranes. Thermodynamic and Structural Aspects.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Calorimetry; Dynamic Light Scattering; Electron Spin Resonance Spectroscopy; Membranes, Artificial; Models, Chemical; Molecular Structure; Olanzapine; Phosphatidylcholines; Phosphatidylglycerols; Protons; Sulpiride; Thermodynamics; Thioridazine; Water | 2017 |
The affinity of antipsychotic drugs to dopamine and serotonin 5-HT
Topics: Amisulpride; Animals; Antipsychotic Agents; Corpus Striatum; Dose-Response Relationship, Drug; Magnetic Resonance Imaging; Male; Neural Pathways; Neuroimaging; Olanzapine; Prefrontal Cortex; Radioligand Assay; Rats; Receptors, Dopamine; Receptors, Serotonin, 5-HT2; Risperidone | 2018 |
Rapid remission of first-episode schizophrenia with standardised treatment.
Topics: Amisulpride; Clozapine; Humans; Olanzapine; Psychotic Disorders; Schizophrenia | 2018 |
Involvement of vascular endothelial growth factor (VEGF) and mitogen-activated protein kinases (MAPK) in the mechanism of neuroleptic drugs.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Cell Line, Tumor; Haloperidol; Humans; Mitogen-Activated Protein Kinases; Neuroprotective Agents; Olanzapine; Pituitary Adenylate Cyclase-Activating Polypeptide; Signal Transduction; Sulpiride; Vascular Endothelial Growth Factor A | 2018 |
Antipsychotic treatments: who is really failing here? - Authors' reply.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Humans; Olanzapine; Psychotic Disorders; Schizophrenia | 2018 |
Antipsychotic treatments: who is really failing here?
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Humans; Olanzapine; Psychotic Disorders; Schizophrenia | 2018 |
Antipsychotics and pituitary tumors: an analysis of the European pharmacovigilance database (EudraVigilance).
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Child; Databases, Factual; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Pharmacovigilance; Pituitary Neoplasms; Pregnancy; Quetiapine Fumarate; Retrospective Studies; Risperidone; Sulpiride; Young Adult | 2019 |
Atypical antipsychotics induce human osteoblasts apoptosis via Wnt/β-catenin signaling.
Topics: Amisulpride; Antipsychotic Agents; Apoptosis; Aripiprazole; beta Catenin; Cell Line; Humans; Olanzapine; Osteoblasts; Resveratrol; Risperidone; Wnt Signaling Pathway | 2019 |
c-Fos expression response to olanzapine, amisulpride, aripiprazole, and quetiapine single administration in the rat forebrain: Effect of a mild stress preconditioning.
Topics: Amisulpride; Animals; Antipsychotic Agents; Aripiprazole; Gene Expression; Injections, Intraventricular; Ischemic Preconditioning; Male; Olanzapine; Prosencephalon; Proto-Oncogene Proteins c-fos; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Stress, Psychological | 2019 |
Spatial relationship between the c-Fos distribution and enkephalinergic, substance P, and tyrosine hydroxylase innervation fields after acute treatment with neuroleptics olanzapine, amisulpride, quetiapine, and aripiprazole in the rat septum.
Topics: Amisulpride; Animals; Antipsychotic Agents; Aripiprazole; Enkephalins; Immunohistochemistry; Male; Neurons; Olanzapine; Proto-Oncogene Proteins c-fos; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Septum of Brain; Substance P; Tissue Distribution; Tyrosine 3-Monooxygenase | 2019 |
[Amisulpride, a one-of-a-kind and highly efficacious antipsychotic agent in the treatment of first-episode psychosis].
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Drug Monitoring; Drug Substitution; Humans; Olanzapine; Patient Selection; Psychotic Disorders; Schizophrenia | 2019 |
Comparative cost-effectiveness of amisulpride and olanzapine in the treatment of schizophrenia in China.
Topics: Amisulpride; Antipsychotic Agents; China; Cost-Benefit Analysis; Decision Support Techniques; Humans; Markov Chains; Olanzapine; Quality-Adjusted Life Years; Schizophrenia; Time Factors | 2020 |
Effects of Atypical Antipsychotics on Neuroactive Vitamins in Patients With Schizophrenia.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Case-Control Studies; Female; Humans; Male; Olanzapine; Paliperidone Palmitate; Schizophrenia; Vitamin A; Vitamin D; Vitamin E; Vitamins; Young Adult | 2020 |
c-Fos and FosB/ΔFosB colocalizations in selected forebrain structures after olanzapine, amisulpride, aripiprazole, and quetiapine single administration in rats preconditioned by two different mild stressors sequences.
Topics: Amisulpride; Animals; Antipsychotic Agents; Aripiprazole; Corpus Striatum; Male; Olanzapine; Proto-Oncogene Proteins c-fos; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Septal Nuclei; Stress, Psychological | 2020 |
Effect of amisulpride, olanzapine, quetiapine, and aripiprazole single administration on c-Fos expression in vasopressinergic and oxytocinergic neurons of the rat hypothalamic supraoptic nucleus.
Topics: Amisulpride; Animals; Antipsychotic Agents; Aripiprazole; Male; Neurons; Olanzapine; Oxytocin; Proto-Oncogene Proteins c-fos; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Supraoptic Nucleus; Vasopressins | 2020 |
Identification and Quantification of Antipsychotics in Blood Samples by LC-MS-MS: Case Reports and Data from Three Years of Routine Analysis.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Female; Forensic Toxicology; Humans; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Substance Abuse Detection; Suicide; Sulpiride; Tandem Mass Spectrometry; Thiazoles | 2020 |
What is the "best intro"-explanatory versus pragmatic antipsychotic drug trials.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Humans; Olanzapine; Schizophrenia | 2020 |
Pragmatic antipsychotics trial-caution in interpretation.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Humans; Olanzapine; Schizophrenia | 2021 |
Pragmatic antipsychotics trial-caution in interpretation - Authors' reply.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Humans; Olanzapine; Schizophrenia | 2021 |
The effect of amisulpride, olanzapine, quetiapine, and aripiprazole single administration on c-Fos expression in vasopressinergic and oxytocinergic neurons of the rat hypothalamic paraventricular nucleus.
Topics: Amisulpride; Animals; Antipsychotic Agents; Aripiprazole; Fluorescent Dyes; Gene Expression Regulation; Genes, fos; Male; Neurons; Olanzapine; Oxytocin; Paraventricular Hypothalamic Nucleus; Proto-Oncogene Proteins c-fos; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Staining and Labeling; Vasopressins | 2021 |
Characteristics of adverse reactions among antipsychotic drugs using the Korean Adverse Event Reporting System database from 2010 to 2019.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Clozapine; Drug-Related Side Effects and Adverse Reactions; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia | 2022 |
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Topics: Adenosine Monophosphate; Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Clopenthixol; Clozapine; Flupenthixol; Fluphenazine; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Pimozide; Quetiapine Fumarate; Risperidone; Sulpiride; Trifluoperazine | 2022 |
Relapse in patients with schizophrenia and amisulpride-induced hyperprolactinemia or olanzapine-induced metabolic disturbance after switching to other antipsychotics.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chronic Disease; Humans; Hyperprolactinemia; Olanzapine; Piperazines; Quinolones; Recurrence; Schizophrenia | 2023 |